miRNA-mediated metabolic reprogramming is associated with recurrence in ovarian cancer.
BACKGROUND Ovarian cancer (OC) recurrence and therapy resistance remain major clinical challenges. Identifying the molecular adaptations associated with relapse is essential for improving disease monitoring. RESEARCH DESIGN AND METHODS We performed miRNA expression profiling on tissue and serum samples obtained from...